Company: SHPH
Filing Date: 2025-08-13
Form Type: 10-Q
Source: 0001641172-25-023263
Chunk: 19

Company: Shuttle Pharmaceuticals Holdings, Inc.
Filing Date: 2025-08-13
Form: 10-Q
Item: Part II, Item 5
Chunk 19
---
 the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to
be signed on its behalf by the undersigned thereunto duly authorized.

    SHUTTLE
    PHARMACEUTICALS HOLDINGS, INC.

    August 12,
2025
    By:
    /s/
    Christopher Cooper

    Christopher
    Cooper

    Interim
    Chief Executive Officer

    (Principal
    Executive Officer)

    August 12,
    2025
    By:
    /s/
    Timothy J. Lorber

    Timothy
    J. Lorber

    Chief
    Financial Officer

    (Principal
    Financial and Accounting Officer)

34